Atlas Trials

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Clinical trial NCT00486382 · COMPLETED

Trial details

NCT number
NCT00486382
Sponsor
Access to Advanced Health Institute (AAHI)
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Visceral LeishmaniasisPost-kala-azar Dermal Leishmaniasis
Start date
2007-04-01
Primary completion
2008-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.